
FluidAI
Developing an implantable biochip to detect post-operative complications.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor investor investor investor investor investor | €0.0 | round |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
N/A | €0.0 | round | |
investor investor | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
investor investor investor investor investor | €0.0 | round | |
investor | €0.0 Valuation: €0.0 | round | |
investor | €0.0 | round | |
* | $15.0m | Series A | |
Total Funding | 000k |
Related Content
FluidAI, formerly known as NERv Technology, is a Canadian medical technology company that has developed an AI-powered platform for the early detection and monitoring of postoperative complications, specifically leaks after general and abdominal surgeries. The company's core product, the Stream™ Platform, is a non-invasive system that continuously analyzes wound fluid from existing catheters to identify potential issues before they become critical. This allows for timely intervention, which can significantly improve patient outcomes and reduce the length and cost of hospital stays.
FluidAI's business model is centered on providing its advanced sensing technology and AI-enabled insights to hospitals and healthcare providers. The company collaborates with healthcare institutions, such as the Mayo Clinic, to further develop and validate its AI-driven solutions. By integrating with existing medical devices and workflows, FluidAI aims to streamline hospital operations and establish a new standard of postoperative care. The company serves the global healthcare market, with a focus on surgical departments and intensive care units.
Keywords: postoperative care, medical technology, artificial intelligence, surgical complications, patient monitoring, leak detection, medical devices, healthcare analytics, digital health, surgical recovery